Category: GreenBook

Alternative Headline: DeSantis Targets Accreditor ‘Cartel’

[MM Curator Summary]: 

Florida and other southern states plan to launch a new conservative-led university accreditor to bypass existing agencies they view as ideologically biased — so that they can mold them to be biased in the "right way." 

====================================

In conjunction with other southern states, Florida is developing a new university accrediting commission in response to existing agencies the governor says require schools to “bend the knee” to get accredited.

During a Thursday news conference at Florida Atlantic University in Boca Raton, Gov. Ron DeSantis announced, alongside State University System Chancellor Ray Rodrigues and university leaders from Texas and South Carolina, that the states are developing a Commission for Public Higher Education.

DeSantis has focused heavily on “woke” ideologies by pushing legislation to ban state spending on diversity, equity, and inclusion, and remaking state higher education institutions to be more conservative.

In the way of his higher education initiatives, he has said, are accrediting agencies that may require a commitment to those values or other expectations for a university to be recognized.

In order to “shape institutions in a positive way,” DeSantis said, “You gotta go two or three levels down sometimes. And we’ve identified this accreditation cartel as an issue for a long time.”

Florida is establishing the commission with the University System of Georgia, the University of North Carolina system, University of South Carolina, the University of Tennessee system, and the Texas A&M University system, which DeSantis said will “upend the monopoly of the woke accreditation cartels.”

The layers, for example, can be shown by a 2023 law, SB 266, which outlawed state spending on diversity, equity, and inclusion, but allowed for DEI initiatives to continue if required to maintain accreditation.

DeSantis, who used to own an LSAT prep company, said during the “woke era” “institutions really became corrupted by ideology, and they were putting ideology ahead of the pursuit of truth during COVID.”

Timeline

DeSantis did not lay out a timeline for when the commission would be up and running, acknowledging that it has to meet federal requirements before the U.S. Department of Education can approve it.

“We’re establishing it. You kind of got to go and actually do it for, you know, some period of time,” DeSantis said, adding, “I think U.S. DOE wants to be quick on this.”

DeSantis said he nudged Rodrigues shortly after Trump won the presidency.

“We didn’t really have the prospects of launching anything like this successfully during the Biden years, but it’s a new day, and I think this is going to make a big big difference,” DeSantis said, adding that if it gets established during the Trump presidency, “then it’s almost impossible for a future federal administration to try to upend the apple cart.”

As recently as 2020, the year after DeSantis took office, the State University System of Florida created a workgroup that, in its final report, concluded that the universities’ “Board of Governors is making a clear and steadfast commitment to prioritize and support diversity, racial and gender equity, and inclusion.”

In 2022, Florida lawmakers approved and DeSantis signed SB 7044 to provoke institutions to seek accreditation from accreditors approved by the State Board of Education or Board of Governors.

Expecting favorability

“I think almost all the states in our region are going to be favorable to this,” DeSantis said.

“All those states have done good stuff in higher ed anyways but, you know, it’s been more difficult when you have this accreditation cartel nipping at you all the time,” he said. “You know, now I think it’s going to be really, really smooth sailing.”

Florida’s and other southern state institutions are members of the Southern Association of Colleges and Schools Commission on Colleges. DeSantis and Rodrigues made jabs at SACSCOC, saying Florida institutions have problems with the accrediting organization and that its member schools’ performance has not been impressive.

“The Commission for Public Higher Education will offer an accreditation model that prioritizes academic excellence and student success while removing ideological bias and unnecessary financial burdens. These reforms will benefit our faculty, our students, and the hardworking taxpayers who fund our public systems,” Rodrigues said.

In an emailed statement to the Phoenix, SACSCOC said, “We welcome any new accreditor as they go through a rigorous approval process. Accreditation is central to quality education; thus accreditors are held to high standards and must themselves be reviewed.”

“As for SACSCOC, we know we currently accredit institutions that serve the largest number of students in the country (approximately 5M),” the organization said. “As such, we will work with our partnering institutions to ensure and strengthen a high standard of accreditation that reflects the needs of students, our institutions, and the workforce.”

DeSantis complained that Florida law schools “should not be captive to having to bend the knee to get accreditation from” the American Bar Association, which he said “mandates explicit DEI compliance as a condition of accreditation” and “has now become a far left activist group.” The association has suspended its DEI standard until at least 2026.

The commission “will create a first-of-its-kind accreditation model for public higher education institutions that will offer high-quality, efficient services prioritizing academic excellence, student outcomes, and achievement,” according to the State University System.

“​​Together, we are leaving behind the legacy systems and failed institutions of the past, while charting a new course in higher education, that puts student success at the forefront of everything that we do,” said Florida Atlantic University President Adam Hasner, who was recently named to that position following outcry from students who feared he would politicize the position.

Union backlash

The Florida Education Association and United Faculty of Florida released a joint statement following DeSantis’ announcement, saying they “strongly oppose” the move as “directly threatens the independence, integrity, and academic credibility of the state’s higher education system.”

“Accreditation matters because it’s the backbone of academic freedom, shared governance, and public trust in the quality of our institutions,” UFF President Teresa M. Hodge said in a news release.

“This proposed state accreditor appears designed to align more with political priorities rather than academic independence. It seems to be the state’s latest attempt to exert top-down control over what faculty can teach and what students are allowed to learn.”

Andrew Spar, president of the FEA, said he is concerned about how a new accreditor might affect teacher preparation programs.

“Students learn best when they’re free to learn and educators are free to teach — not when curriculum decisions are dictated by politics,” Spar said.

The commission’s announced core principles:

• It is appropriate and necessary to introduce competition, aligned with state and institutional needs, into the existing marketplace of university accreditation.
• It is in the best interests of all interested parties, including students, to launch an accrediting body comprised of true peer institutions focused on public colleges and universities and their governing university systems.
• It is imperative to reduce bureaucracy through a more efficient and focused accreditation process, which will result in lower costs and significant time savings for member institutions, and which will translate into lower tuition prices for students and families.
• It is critical to ensure that this new accrediting body is accountable to the states of the member institutions.
• It is necessary for the new accrediting body to become and remain recognized by the U.S. Department of Education for the purposes of Title IV participation by its accredited institutions.

https://www.orlandoweekly.com/news/after-scrutiny-desantis-says-10-million-payment-to-hope-florida-program-is-not-illegal-but-a-cherry-on-top-39274575

COLOR CODE: 

General item, but important. Gets at main point of article= YELLOW

Has a dollar amount or number = GREEN

A specific topic that seems to be different than other topics = BLUE

Alternative Headline: Most Medicaid Plans Cover Naloxone

[MM Curator Summary]: Most Medicaid Managed Care Plans cover naloxone, but restrictions and cost barriers still limit access for low-income populations most at risk of overdose.

====================================

Majority of Medicaid Managed Care Plans Cover Opioid Overdose Reversal Drug Naloxone

A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may still prevent people from accessing this life-saving drug.

In 2023, the US Food and Drug Administration approved the overdose reversal drug naloxone, commonly known as Narcan, for over-the counter (OTC) use. While hailed as a public health success for increasing access to this life-saving drug, this OTC option remains out of reach for people who cannot afford the $45 average price tag for a two-dose box.

Medicaid recipients are a low-income population that disproportionately experiences opioid overdoses, so access to low- or no-cost naloxone through insurance can help to save lives. A new study led by the School of Public Health investigated Medicaid managed care plan coverage of naloxone across the nation.

Published in JAMA Network Open, the study found that almost all Medicaid managed care plans (MCPs) cover at least one of the four formulations of naloxone. Eighty percent of Medicaid recipients, which include more than 70 million people, are enrolled in these plans. The study is the first to assess naloxone coverage within MCPs.

“These findings are important because over-the-counter naloxone can still be very expensive and insurance coverage can remove the cost barrier to accessing this drug,” says study lead and corresponding author Sage Feltus, research associate in the Department of Health Law, Policy & Management. “The overdose death rate among Medicaid beneficiaries is twice as high as the overdose rate among the general US population. Low-barrier and low-cost naloxone could help get this essential medication into the hands of people who are at high risk for overdose death.”

The study’s senior author is Maureen Stewart, research associate professor in HLPM at BUSPH, and coauthors include Jeffrey Bratberg, clinical professor at The University of Rhode Island College of Pharmacy, and Sophia Balkovski, a doctoral trainee at the Heller School for Social Policy and Management at Brandeis University.

After rising sharply during the COVID-19 pandemic, drug overdose deaths involving opioids declined to 83,140 in 2023, followed by a significant drop to 54,743 deaths in 2024, according to provisional data from the Centers for Disease Control and Prevention. Naloxone, which is considered the cornerstone of the harm-reduction approach to the nation’s opioid overdose emergency, can quickly reverse the effects of opioids such as heroin, oxycodone, and fentanyl. Experts have long sought to increase awareness of and access to this medication to safely and effectively reduce deaths from opioid use.

For the study, the researchers reviewed the preferred drug lists from 264 MCPs that covered 65.3 million Medicaid recipients in 40 states and Washington, DC. Insurance companies and states can use these preferred drug lists to negotiate rebates with drug manufacturers. The team examined MCP reported coverage and management of all available formulations of naloxone: brand and generic 4-mg nasal sprays; a generic injectable; and a newer, high-dose, brand nasal spray in 8 mg. They also reviewed publicly available data on state-level opioid overdose deaths.

The above figure illustrates the proportion of Medicaid managed care plans in states covering at least one generic injectable or generic or brand intranasal naloxone formulation without any restrictions. Crosshatch pattern indicates the state had an opioid overdose death rate per 100000 people in the 75th percentile or above (32.5%).

While quantity limits and other restrictions varied by plan, 94 percent of plans reported covering at least one generic injectable or 4-mg generic/brand versions of the nasal spray of naloxone, and 91 percent covered the 4-mg generic or brand nasal spray and injectable formulations. The generic versions of the drug were the most common forms listed on PDLs. Over half of plans (covering 42 million Medicaid recipients) had state-defined PDLs, and these plans were less likely to report covering the generic injectable naloxone.

Notably, three states with no MCPs covering at least one form of naloxone—Ohio, Kentucky, and Tennessee—had high opioid overdose rates, although the researchers caution that more data is needed to understand the causes of these high death rates. The findings did show that MCPs in states with low overdose rates were more likely to cover all forms of naloxone and less likely to impose quantity limits. Further research should identify how Medicaid coverage of naloxone contributes to recipients’ health, and MCPs should work to ease restrictions that make it difficult for people to actually receive this medication.

“Reporting coverage is a critical first step,” Feltus says. “Removing prior authorization requirements may ease administrative burden for providers prescribing naloxone. We don’t know as much about the impact of quantity limits on naloxone but this restriction could present a barrier for Medicaid recipients who may need more than the allowed amount per month or year.”

States can take action to increase access to naloxone, she adds. 

“States can require that MCPs cover all forms of naloxone by including all formulations on a uniform preferred drug list, or in contract requirements with MCPs.”

https://www.bu.edu/sph/news/articles/2025/majority-of-medicaid-managed-care-plans-cover-opioid-overdose-reversal-drug-naloxone/

COLOR CODE: 

General item, but important. Gets at main point of article= YELLOW

Has a dollar amount or number = GREEN

A specific topic that seems to be different than other topics = BLUE